Insider Shareholders with Direct Ownership of Processa Pharmaceuticals, Inc. (PCSA)
This section provides a comprehensive overview of the insiders with direct ownership of Processa Pharmaceuticals, Inc. (PCSA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Processa Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 30,000 | 476,700 | 648,300 $596,436 | 7 |
Apr 08, 2021
Reduced 38.16%
|
|
|
George K Ng
Chief Executive Officer |
200,000 | 0 | 200,000 $184,000 | 2 |
Oct 12, 2023
Added 33.33%
|
|
Robert Michael Floyd
Chief Operating Officer |
37,000 | 22,826 | 82,267 $75,685 | 8 |
Feb 09, 2023
Added 10.84%
|
|
David Young
Pres. Research & Development |
506,223 | 13,099 | 80,905 $74,432 | 21 |
Jul 10, 2024
Reduced 0.35%
|
| 69,799 | 0 | 75,729 $69,670 | 6 |
Oct 12, 2023
Added 7.34%
|
|
|
Khalid Islam
Director |
4,392 | 0 | 72,486 $66,687 | 1 |
Mar 31, 2022
Added 5.71%
|
| 53,075 | 0 | 57,613 $53,003 | 6 |
Oct 10, 2023
Added 7.24%
|
|
|
Patrick Lin
Chief Business - Strategy Off |
105,146 | 4,005 | 29,059 $26,734 | 22 |
Jul 10, 2024
Reduced 0.92%
|
| 27,955 | 0 | 27,955 $25,718 | 2 |
Jun 27, 2023
Added 35.6%
|
|
|
Sian Bigora
Chief Development Officer |
19,196 | 961 | 21,878 $20,127 | 8 |
Jul 10, 2024
Reduced 1.02%
|
| 6,731 | 0 | 16,693 $15,357 | 3 |
Aug 05, 2022
Added 6.54%
|
|
| 14,407 | 0 | 14,407 $13,254 | 1 |
Jun 27, 2023
Added 50.0%
|
|
|
Wendy Guy
Chief Administrative Officer |
33,967 | 4,992 | 11,857 $10,908 | 10 |
Jul 10, 2024
Reduced 1.82%
|
|
James H Stanker
Chief Financial Officer |
76,196 | 3,780 | 6,482 $5,963 | 14 |
Jul 10, 2024
Reduced 4.17%
|